Association of the Human Papillomavirus Type 16 E7 Oncoprotein with the 600-kDa Retinoblastoma Protein-associated Factor, P600

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 Aug 3

PMID 16061792

Citations 111

Authors

Kyung-Won Huh

Joseph DeMasi

Hidesato Ogawa

Yoshihiro Nakatani

Peter M Howley

Karl Munger

Affiliations

Soon will be listed here.

Abstract

The human papillomavirus type 16 (HPV-16) E7 gene encodes a multifunctional oncoprotein that can subvert multiple cellular regulatory pathways. The best-known cellular targets of the HPV-16 E7 oncoprotein are the retinoblastoma tumor suppressor protein pRB and the related pocket proteins p107 and p130. However, there is ample evidence that E7 has additional cellular targets that contribute to its transforming potential. We isolated HPV-16 E7 associated cellular protein complexes by tandem affinity purification and mass spectrometry and identified the 600-kDa retinoblastoma protein associated factor, p600, as a cellular target of E7. Association of E7 with p600 is independent of the pocket proteins and is mediated through the N terminal E7 domain, which is related to conserved region 1 of the adenovirus E1A protein and importantly contributes to cellular transformation independent of pRB binding. Depletion of p600 protein levels by RNA interference substantially decreased anchorage-independent growth in HPV-positive and -negative human cancer cells. Therefore, p600 is a cellular target of E7 that regulates cellular pathways that contribute to anchorage-independent growth and cellular transformation.

Citing Articles

Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis.

Wootton L, Morgan E Oncogene. 2025; 44(11):713-723.

PMID: 40011575 PMC: 11888991. DOI: 10.1038/s41388-025-03310-6.

The Natural History of Cervical Cancer and the Case for MicroRNAs: Is Human Papillomavirus Infection the Whole Story?.

Palomino-Vizcaino G, Banuelos-Villegas E, Alvarez-Salas L Int J Mol Sci. 2024; 25(23.

PMID: 39684702 PMC: 11641362. DOI: 10.3390/ijms252312991.

The HPV101 E7 protein shares host cellular targets and biological activities with high-risk HPV16 E7.

Gelbard M, Grace M, von Schoeler-Ames A, Gnanou I, Munger K Tumour Virus Res. 2024; 19():200300.

PMID: 39643241 PMC: 11714379. DOI: 10.1016/j.tvr.2024.200300.

What are the essential determinants of human papillomavirus carcinogenesis?.

Munger K, White E mBio. 2024; 15(11):e0046224.

PMID: 39365046 PMC: 11558995. DOI: 10.1128/mbio.00462-24.

HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.

Blakely W, Hatterschide J, White E bioRxiv. 2024; .

PMID: 38496413 PMC: 10942435. DOI: 10.1101/2024.03.07.583953.

References

Varshavsky A . The N-end rule and regulation of apoptosis. Nat Cell Biol. 2003; 5(5):373-6. DOI: 10.1038/ncb0503-373. View

Scheffner M, Munger K, Byrne J, Howley P . The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A. 1991; 88(13):5523-7. PMC: 51909. DOI: 10.1073/pnas.88.13.5523. View

Duensing S, Munger K . Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol. 2003; 77(22):12331-5. PMC: 254291. DOI: 10.1128/jvi.77.22.12331-12335.2003. View

Balsitis S, Sage J, Duensing S, Munger K, Jacks T, Lambert P . Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo. Mol Cell Biol. 2003; 23(24):9094-103. PMC: 309665. DOI: 10.1128/MCB.23.24.9094-9103.2003. View

Nakatani Y, Ogryzko V . Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 2004; 370:430-44. DOI: 10.1016/S0076-6879(03)70037-8. View

Duensing S, Munger K . Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer. 2004; 109(2):157-62. DOI: 10.1002/ijc.11691. View

Psyrri A, DeFilippis R, Edwards A, Yates K, Manuelidis L, DiMaio D . Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res. 2004; 64(9):3079-86. DOI: 10.1158/0008-5472.can-03-3739. View

Munger K, Baldwin A, Edwards K, Hayakawa H, Nguyen C, Owens M . Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004; 78(21):11451-60. PMC: 523272. DOI: 10.1128/JVI.78.21.11451-11460.2004. View

Schwarz E, Freese U, Gissmann L, Mayer W, Roggenbuck B, Stremlau A . Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985; 314(6006):111-4. DOI: 10.1038/314111a0. View

10.

Yee C, Baker C, Schlegel R, Howley P . Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol. 1985; 119(3):361-6. PMC: 1888002. View

11.

Baker C, Phelps W, Lindgren V, Braun M, Gonda M, Howley P . Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol. 1987; 61(4):962-71. PMC: 254051. DOI: 10.1128/JVI.61.4.962-971.1987. View

12.

Wrede D, Tidy J, Crook T, Lane D, Vousden K . Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol Carcinog. 1991; 4(3):171-5. DOI: 10.1002/mc.2940040302. View

13.

Phelps W, Munger K, Yee C, Barnes J, Howley P . Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol. 1992; 66(4):2418-27. PMC: 289037. DOI: 10.1128/JVI.66.4.2418-2427.1992. View

14.

Madura K, Dohmen R, Varshavsky A . N-recognin/Ubc2 interactions in the N-end rule pathway. J Biol Chem. 1993; 268(16):12046-54. View

15.

Vande Pol S, Howley P . Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes. J Virol. 1995; 69(1):395-402. PMC: 188587. DOI: 10.1128/JVI.69.1.395-402.1995. View

16.

Richards S, Hillman T, Stern M . Mutations in the Drosophila pushover gene confer increased neuronal excitability and spontaneous synaptic vesicle fusion. Genetics. 1996; 142(4):1215-23. PMC: 1207119. DOI: 10.1093/genetics/142.4.1215. View

17.

Boyer S, Wazer D, Band V . E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996; 56(20):4620-4. View

18.

Jones D, Munger K . Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol. 1997; 71(4):2905-12. PMC: 191417. DOI: 10.1128/JVI.71.4.2905-2912.1997. View

19.

Jones D, Thompson D, Munger K . Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 1998; 239(1):97-107. DOI: 10.1006/viro.1997.8851. View

20.

Thompson D, Belinsky G, Chang T, Jones D, Schlegel R, Munger K . The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene. 1998; 15(25):3025-35. DOI: 10.1038/sj.onc.1201495. View